share_log

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

HC Wainwright & Co.重申買入瑞格製藥,維持15美元的目標股價
Benzinga ·  01/04 10:27

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $15 price target.

HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯重申了銳傑製藥(納斯達克股票代碼:RIGL)的買入並維持15美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論